United Kingdom (GB)

Predictors of Access to Rehabilitation in the Year Following Traumatic Brain Injury: A European Prospective and Multicenter Study (2020) Jacob L, Cogne M, Tenovuo O, Roe C, Andelic N, Majdan M, Ranta J, et al. Journal article A data-driven approach to optimising the encoding for multi-shell diffusion MRI with application to neonatal imaging (2020) Tournier JD, Christiaens D, Hutter J, Price AN, Cordero-Grande L, Hughes E, Bastiani M, et al. Journal article Heterogeneity in brain microstructural development following preterm birth (2020) Dimitrova R, Pietsch M, Christiaens D, Ciarrusta J, Wolfers T, Batalle D, Hughes E, et al. Journal article Strict comparison for C∗ -algebras arising from almost finite groupoids (2020) Ara P, Bonicke C, Bosa J, Li K Journal article 3D Morphable Face Modelsa-Past, Present, and Future (2020) Egger B, Smith WAP, Tewari A, Wuhrer S, Zollhoefer M, Beeler T, Bernard F, et al. Journal article Layer-by-layer assemblies of biopolymers: Build-up, mechanical stability and molecular dynamics (2020) Campbell J, Vikulina AS Journal article, Review article IMPROVED CARDIAC RISK STRATIFICATION IN INDIVIDUALS WITH HIGH RISK PLAQUE FEATURES USING THE PERIVASCULAR FAT ATTENUATION INDEX ON CCTA (2020) Kotanidis CP, Oikonomou EK, Kluener L, Thomas KE, Alashi A, Antonopoulos AS, Shirodaria C, et al. Conference contribution PERIVASCULAR FAT ATTENUATION INDEX MAPPING AROUND THE RIGHT AND LEFT CORONARY ARTERY INDEPENDENTLY PREDICT CARDIAC MORTALITY (2020) Kotanidis CP, Oikonomou EK, Thomas KE, Alashi A, Antonopoulos AS, Shirodaria C, Neubauer S, et al. Conference contribution Characteristics of the first 615 patients enrolled in Pacific R: A study of the first real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy (2020) Girard N, Fietkau R, Garassino M, Garrido P, Field JK, Peters S, Smit HJM, et al. Conference contribution EPIK-B3: A phase III, randomised, double-blind (DB), placebo (PBO)-controlled study of alpelisib (ALP) plus nab-paclitaxel (nabPTX) in advanced triple-negative breast cancer (TNBC) with either PIK3CA mutation or phosphatase and tensin homolog (PTEN) loss without PIK3CA mutation (2020) Sharma P, Farooki A, Fasching P, Loi S, Peterson K, Prat A, Tripathy D, et al. Conference contribution